BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4987191)

  • 21. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract]   [Full Text] [Related]  

  • 22. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen.
    Torisu M; Yokoyama T; Amemiya H; Kohler PF; Schroter G; Martineau G; Penn I; Palmer W; Halgrimson CG; Putnam CW; Starzl TE
    Ann Surg; 1971 Oct; 174(4):620-39. PubMed ID: 4999690
    [No Abstract]   [Full Text] [Related]  

  • 24. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract]   [Full Text] [Related]  

  • 25. [Malignant tumors following transplantation. Case reports and review of the literature].
    Guisan Y; Enderlin F; Harder F; Brunner F; Thiel G; Bernhardt JP; Schädeli J; Mihatsch M
    Schweiz Med Wochenschr; 1973 Apr; 103(16):577-85. PubMed ID: 4610738
    [No Abstract]   [Full Text] [Related]  

  • 26. The complement system in renal homograft recipents.
    Yokoyama T; Torisu M; Durst AL; Schroter G; Groth CG; Starzl TE
    Surgery; 1972 Oct; 72(4):611-8. PubMed ID: 4560540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prolonged ischemic tolerance time of the human liver with successful grafting (author's transl)].
    Lie TS; Käufer C; Siedek M; Prange CH; Rommelsheim K; Fillmann B; Gütgemann A
    MMW Munch Med Wochenschr; 1974 May; 116(20):1013-20. PubMed ID: 4368015
    [No Abstract]   [Full Text] [Related]  

  • 28. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC
    Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
    [No Abstract]   [Full Text] [Related]  

  • 29. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical aspects of allograft rejection.
    Williams GM
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
    [No Abstract]   [Full Text] [Related]  

  • 31. Minimum steroid requirements in the late post-transplant period.
    Turcotte JG; Dickerman RM; Harper ML
    Transplant Proc; 1975 Mar; 7(1):83-8. PubMed ID: 1091049
    [No Abstract]   [Full Text] [Related]  

  • 32. Preliminary studies on antithymocyte globulin.
    Orlowski T; Skopińska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
    Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
    [No Abstract]   [Full Text] [Related]  

  • 33. Some critical remarks and suggestions about antilymphocyte serum.
    Grabar P
    Transplant Proc; 1972 Sep; 4(3):407-13. PubMed ID: 4628101
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver transplantation: a clinical and immunological appraisal.
    Williams R; Smith MG
    Prog Liver Dis; 1972; 4():433-46. PubMed ID: 4569007
    [No Abstract]   [Full Text] [Related]  

  • 35. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation.
    Freise CE; Hebert M; Osorio RW; Nikolai B; Lake JR; Kauffman RS; Ascher NL; Roberts JP
    Transplant Proc; 1993 Apr; 25(2):1758-9. PubMed ID: 8470155
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

  • 37. Liver transplantation.
    Starzl TE
    Z Gastroenterol; 1978 Dec; 16(12):725-38. PubMed ID: 369162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation in a patient with developmental interruption of the inferior vena cava with azygos substitution.
    Zinser MJ; Hanto DW
    Transplant Proc; 2012 Jun; 44(5):1460-3. PubMed ID: 22664037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract]   [Full Text] [Related]  

  • 40. Orthotopic liver transplantation in man.
    Starzl TE; Brettschneider L; Penn I; Bell P; Groth CG; Blanchard H; Kashiwagi N; Putnam CW
    Transplant Proc; 1969 Mar; 1(1):216-22. PubMed ID: 4332530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.